Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Novel Thermal Ablation System for Transdermal Drug Delivery

By Kumamoto University | July 27, 2017

Near-infrared light produces a photothermal effect on gold nanorods in a hydrogel skin patch. This heats the skin thereby increasing the permeability of the outermost layer, the stratum corneum (SC), which allows significant transdermal delivery of fluorescently labeled ovalbumin. The goal of this research is the effective delivery of protein-based drugs through the skin. (Image reprinted from the European Journal of Pharmaceutics and Biopharmaceutic, 119, Haine, A. T.; Koga, Y.; Hashimoto, Y.; Higashi, T.; Motoyama, K.; Arima, H. & Niidome, T., Enhancement of transdermal protein delivery by photothermal effect of gold nanorods coated on polysaccharide-based hydrogel, 91-95, (2017), with permission from Elsevier.) Source: Professor Takuro Niidome

Many diseases are treated with protein-based drugs. However, due to the size of the molecules, the only effective delivery method is through injection, which can suffer from low patient compliance. Furthermore, many of these types of drugs require multiple treatments that can take hours to complete, as is the case with rheumatoid arthritis. New drug delivery methods should be discovered and implemented to relieve patients of this taxing and expensive experience.

In an attempt to produce a better drug delivery system, researchers from Kumamoto University in Japan focused on a transdermal protein delivery system. There are multiple techniques currently being studied for this type of drug delivery mechanism, from microneedles to iontophoresis (transdermal drug delivery via electric current), but the Kumamoto University researchers designed to improve a technique called transdermal thermal ablation. This technique increases the permeability of the skin by heating and removing the first skin layer, the stratum corneum (SC). The difficulty is performing this without damaging deeper skin layers.

The researchers used a combination of transparent gel patches, gold nanorods, and near-infrared (NIR) light to create a unique thermal ablation system for transdermal drug delivery. They added fluorescently labeled ovalbumin (FITC-OVA) to the patches to determine the extent of protein translocation after NIR irradiation on murine skin. Both in vivo and in vitroexperiments were performed using gel patches with gold nanorods, gel patches without gold nanorods (control 1), and gel patches with gold nanorods but without any form of irradiation (control 2). The two controls did not produce any thermal ablation effect on the skin, but the NIR irradiated gold nanorod patches heated the skin to around 43 degrees Celsius. This resulted in significant protein translocation for the in vitro experiment and moderate translocation for the in vivo experiment. The difference between these two results was likely due to a loosening of the skin cells after freezing for the in vitro experiment.

“Our experiments have shown that the photothermal effect on gold nanorods by irradiation of near-infrared light causes the skin to heat up and become more permeable,” said Professor Takuro Niidome, leader of the research project. “It should be noted that our technique has yet to deliver any specific protein drugs, but we are confident that the research will contribute to the development of effective transdermal delivery systems.”

This research can be found online in Elsevier’s European Journal of Pharmaceutics and Biopharmaceutics.


Filed Under: Drug Discovery

 

Related Articles Read More >

Chemical formula of psilocybin
Psychedelic pioneer Compass files for FDA approval as rivals close in
Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027
If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE